Evidence map›Paper›PMID 25775048›Full record

Trial reportJAMA internal medicine2015

A targeted infection prevention intervention in nursing home residents with indwelling devices: a randomized clinical trial.

Lona Mody, Sarah L Krein, Sanjay Saint, Lillian C Min, Ana Montoya, Bonnie Lansing, Sara E McNamara, Kathleen Symons, Jay Fisch, Evonne Koo and 7 more

Erratum issued 2 registry-linked trialsOpen access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA internal medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 73 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 4 pooled it
38.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01062841 nacompletednot on this map

Targeted Infection Control Program (TIP) to Reduce Resistant Pathogens and Infections

TypeinterventionalSponsorUniversity of MichiganRan2010 to 2013Enrolled418ConditionsInfectionArmsTargeted Infection Control
NCT04075344 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Effect of a Multimodal Infection Control Program on the Reduction of Bacterial Contamination on Nasogastric Tube Feeding for Elderly Persons in Residential Care Home

TypeinterventionalSponsorChinese University of Hong KongRan2019 to 2020Enrolled67ConditionsInfection, BacterialArmsMultimodal Infection control programme
3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 4 syntheses or guidelines pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Observational
  11. Impact of a Collaboration-Focused Intervention to Prevent Healthcare-Associated Infections Before and During the COVID-19 Pandemic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Provider adherence to training components from theContemporary clinical trials communications · 2022
    Article
  17. Molecular Detection ofArchives of Razi Institute · 2022
    Article
  18. Review
  19. Article
  20. Observational

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Lona ModyDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor2Geriatric Research, Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Sarah L KreinCenter for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan4Division of General Medicine, University of Michigan Health System, Ann Arbor.
Sanjay SaintCenter for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan4Division of General Medicine, University of Michigan Health System, Ann Arbor.
Lillian C MinDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor2Geriatric Research, Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Ana MontoyaDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
Bonnie LansingDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
Sara E McNamaraDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
Kathleen SymonsInfectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Jay FischDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor6currently with the Rosenstiel School of Marine and Atmospheric Science, University of Miami, Miami, Florida.
Evonne KooDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
Ruth Anne Ryecurrently a long-term care infection prevention and control consultant in Hemlock, Michigan.
Andrzej GaleckiDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor8Department of Biostatistics, University of Michigan Medical School, Ann Arbor.
Mohammed U KabetoDivision of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
James T FitzgeraldGeriatric Research, Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan9Department of Medical Education, University of Michigan Medical School, Ann Arbor.
Russell N OlmstedDepartment of Infection Prevention and Control, St Joseph Mercy Health System, Ann Arbor, Michigan.
Carol A KauffmanInfectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan11Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
Suzanne F BradleyInfectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan11Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
University of Michigan–Ann Arbor · USVA Ann Arbor Healthcare System · USGeriatric Research Education and Clinical Center · USMercy Health System · USUniversity of Miami · US

Funding

Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Neil Alexander · 2004 to 2026
$29.2M
Pathway from Functional Disability to Antimicrobial Resistance in Nursing HomesR01AG041780 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MODY, LONA · 2013 to 2017
$1.8M
Targeted Infection Prevention (TIP) Program in Nursing HomesR01AG032298 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MODY, LONA · 2009 to 2013
$1.7M
Preventing Infections and Antimicrobial Resistance in the Aging Population: Translational Research and Training ProgramK24AG050685 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Lona Mody · 2015 to 2026
$1.4M
NIA NIH HHS K23AG028943NIA NIH HHS K24 AG050685NIA NIH HHS P30 AG024824NIA NIH HHS R01 AG032298NIA NIH HHS R01AG032298NIA NIH HHS R01 AG041780NIA NIH HHS R01AG041780
6 · The paper itself

Abstract

importanceIndwelling devices (eg, urinary catheters and feeding tubes) are often used in nursing homes (NHs). Inadequate care of residents with these devices contributes to high rates of multidrug-resistant organisms (MDROs) and device-related infections in NHs.

objectiveTo test whether a multimodal targeted infection program (TIP) reduces the prevalence of MDROs and incident device-related infections. DESIGN, SETTING, AND

participantsRandomized clinical trial at 12 community-based NHs from May 2010 to April 2013. Participants were high-risk NH residents with urinary catheters, feeding tubes, or both.

interventionsMultimodal, including preemptive barrier precautions, active surveillance for MDROs and infections, and NH staff education. MAIN OUTCOMES AND MEASURES: The primary outcome was the prevalence density rate of MDROs, defined as the total number of MDROs isolated per visit averaged over the duration of a resident's participation. Secondary outcomes included new MDRO acquisitions and new clinically defined device-associated infections. Data were analyzed using a mixed-effects multilevel Poisson regression model (primary outcome) and a Cox proportional hazards model (secondary outcome), adjusting for facility-level clustering and resident-level variables.

resultsIn total, 418 NH residents with indwelling devices were enrolled, with 34,174 device-days and 6557 anatomic sites sampled. Intervention NHs had a decrease in the overall MDRO prevalence density (rate ratio, 0.77; 95% CI, 0.62-0.94). The rate of new methicillin-resistant Staphylococcus aureus acquisitions was lower in the intervention group than in the control group (rate ratio, 0.78; 95% CI, 0.64-0.96). Hazard ratios for the first and all (including recurrent) clinically defined catheter-associated urinary tract infections were 0.54 (95% CI, 0.30-0.97) and 0.69 (95% CI, 0.49-0.99), respectively, in the intervention group and the control group. There were no reductions in new vancomycin-resistant enterococci or resistant gram-negative bacilli acquisitions or in new feeding tube-associated pneumonias or skin and soft-tissue infections. CONCLUSIONS AND RELEVANCE: Our multimodal TIP intervention reduced the overall MDRO prevalence density, new methicillin-resistant S aureus acquisitions, and clinically defined catheter-associated urinary tract infection rates in high-risk NH residents with indwelling devices. Further studies are needed to evaluate the cost-effectiveness of this approach as well as its effects on the reduction of MDRO transmission to other residents, on the environment, and on referring hospitals.

trial registrationclinicaltrials.gov Identifier: NCT01062841.

Indexed as

Homes for the AgedNursing HomesProsthesis-Related InfectionsAgedAged, 80 and overAnti-Bacterial AgentsCombined Modality TherapyDrug Resistance, Multiple, BacterialFemaleHumansIntubation, GastrointestinalMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedOutcome and Process Assessment, Health CareStaff DevelopmentAnti-Bacterial Agents

Identifiers

PMID25775048
PMCPMC4420659
OpenAlexW1970752957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.